NU 578 Units 1-5 Exam
Pharmacology for Advanced Practice Nurses
200 Verified Questions & Answers With Rationales
A+ GRADED !
This comprehensive examination contains 200 original, verified questions spanning four core
domains: Pharmacokinetics, Pharmacodynamics, and Drug Interactions; Cardiovascular,
Respiratory, and Renal Pharmacology; Neurologic, Psychiatric, and Endocrine Pharmacology;
and Gastrointestinal, Immunologic, and Special Population Pharmacology. Every question has
been written originally for the Academic Year 2026/2027 to reinforce the official University
of South Alabama College of Nursing NU 578 Units 1-5 course objectives, supporting actual
exam readiness, clinical proficiency, and safe prescriptive decision-making. Each item pairs a
clinically accurate stem with four options and a concise rationale grounded in foundational
advanced pharmacology textbooks and current prescribing guidelines, so the reasoning behind
every correct option is transparent and instructive. Work through each domain in sequence,
record your results on the domain score tracker, and revisit the rationales for any question you
miss before sitting your actual exam.
Domain 1: Pharmacokinetics, Pharmacodynamics, and Drug Interactions (Qs 1-50)
Domain 2: Cardiovascular, Respiratory, and Renal Pharmacology (Qs 51-100)
Domain 3: Neurologic, Psychiatric, and Endocrine Pharmacology (Qs 101-150)
Domain 4: Gastrointestinal, Immunologic, and Special Population Pharmacology (Qs 151-200)
DOMAIN 1: Pharmacokinetics, Pharmacodynamics, and Drug Interactions
Questions 1-50
Question 1. A patient with acute angina is instructed to use sublingual nitroglycerin rather
than an oral tablet. Which pharmacokinetic principle explains this route selection?
A. The sublingual route produces a longer duration of action than the oral route
B. Nitroglycerin is too acidic to be absorbed from the stomach
C. Extensive hepatic first-pass metabolism inactivates oral nitroglycerin, while sublingual
absorption bypasses the portal circulation
,D. Oral nitroglycerin induces its own metabolism within the first week
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism, so little intact
drug survives the portal circulation after oral dosing. Sublingual absorption enters systemic
capillaries directly, producing therapeutic levels within one to three minutes, which is why
this route is chosen for rapid relief.
Question 2. A loading dose of phenytoin is ordered before maintenance therapy begins.
What is the purpose of a loading dose?
A. It prevents saturation of hepatic metabolic enzymes
B. It rapidly fills the volume of distribution so therapeutic plasma concentration is reached
without waiting for gradual accumulation
C. It shortens the elimination half-life of the drug
D. It reduces plasma protein binding to free more drug
Correct Answer: B
Rationale: A loading dose equals the desired plasma concentration multiplied by the
volume of distribution. Because phenytoin has a long half-life, reaching steady state by
simple accumulation could take a week or longer; a loading dose achieves therapeutic
concentrations promptly.
Question 3. A patient starts metoprolol tartrate 25 mg twice daily. Approximately how
long does it take to reach steady-state plasma concentrations with consistent dosing?
A. About four to five elimination half-lives
B. After the first dose reaches its peak concentration
C. After ten elimination half-lives
D. Once renal excretion exceeds hepatic metabolism
Correct Answer: A
Rationale: With fixed intermittent dosing, plasma concentrations accumulate toward
steady state in a first-order fashion, reaching about ninety-four percent after four half-
lives and ninety-seven percent after five. Accumulation therefore depends on the half-life,
not on the timing of the first peak.
,Question 4. When a patient's daily phenytoin dose is increased from 300 mg to 400 mg,
the plasma level rises disproportionately. What explains this observation?
A. Plasma protein binding rises at higher concentrations
B. Competition develops for renal tubular secretion
C. Hepatic metabolism becomes saturated, producing zero-order kinetics within the
therapeutic range
D. Gastric emptying is delayed at higher doses
Correct Answer: C
Rationale: Phenytoin is a classic example of a drug that saturates its metabolizing
enzymes at clinical concentrations. Once enzyme capacity is exceeded, a constant amount
is metabolized per unit time, so small dose increases produce large, unpredictable jumps
in plasma level; titration proceeds in small increments with level monitoring.
Question 5. Rifampin is added for a patient stabilized on warfarin. What should the
prescriber anticipate?
A. An elevated INR from inhibited warfarin metabolism
B. No interaction, because rifampin does not affect hepatic enzymes
C. Increased warfarin protein binding with reduced effect
D. A reduced INR from hepatic enzyme induction, often requiring a warfarin dose increase
with close monitoring
Correct Answer: D
Rationale: Rifampin is a potent inducer of CYP2C9 and CYP3A4, which accelerates
warfarin clearance and weakens anticoagulation over one to two weeks. The INR is
monitored closely and the warfarin dose adjusted; when rifampin is discontinued, the
induction fades and the dose must be reduced again.
Question 6. Clarithromycin is prescribed for a patient taking simvastatin 40 mg daily.
What is the safest prescriber action?
A. Temporarily hold the statin or switch to a statin not dependent on CYP3A4
B. Double the simvastatin dose during the infection
C. Add coenzyme Q10 to neutralize the interaction
D. Continue both agents unchanged because no interaction exists
Correct Answer: A
, Rationale: Clarithromycin strongly inhibits CYP3A4, markedly raising simvastatin exposure
and the risk of myopathy and rhabdomyolysis. Holding the statin or using pravastatin or
rosuvastatin, which avoid CYP3A4 metabolism, removes the hazard during the
antimicrobial course.
Question 7. Trimethoprim-sulfamethoxazole is started for a patient taking warfarin. Which
interaction is most important to monitor in the first several days?
A. Permanent induction of warfarin metabolism
B. Inactivation of warfarin within the intestinal lumen
C. Displacement of warfarin from albumin transiently raises the free fraction and the
anticoagulant effect
D. Doubling of warfarin protein binding with reduced effect
Correct Answer: C
Rationale: Both drugs are highly protein bound; sulfonamide competition displaces
warfarin from albumin, transiently increasing free drug until elimination re-equilibrates.
Combined with CYP2C9 inhibition by the combination agent, the INR can climb, so early
INR monitoring and bleeding precautions are warranted.
Question 8. A 78-year-old patient with a creatinine clearance of 24 mL/min requires
enoxaparin for deep vein thrombosis. What prescribing adjustment is required?
A. Give the standard dose because enoxaparin is cleared hepatically
B. Reduce the treatment dose and lengthen the dosing interval because renal elimination
causes accumulation
C. Double the prophylactic dose to compensate for renal function
D. Administer the drug by deep intramuscular injection instead
Correct Answer: B
Rationale: Low-molecular-weight heparins are cleared renally, so severe renal impairment
leads to accumulation and bleeding. Treatment dosing is reduced to once daily (1 mg/kg)
when creatinine clearance falls below 30 mL/min, or unfractionated heparin is selected
because its shorter effect can be managed rapidly if bleeding occurs.
Question 9. Amiodarone is initiated for a patient taking digoxin 0.25 mg daily. What
change should be made?
A. Increase digoxin because amiodarone induces its metabolism
B. No dose change is needed for this combination
Pharmacology for Advanced Practice Nurses
200 Verified Questions & Answers With Rationales
A+ GRADED !
This comprehensive examination contains 200 original, verified questions spanning four core
domains: Pharmacokinetics, Pharmacodynamics, and Drug Interactions; Cardiovascular,
Respiratory, and Renal Pharmacology; Neurologic, Psychiatric, and Endocrine Pharmacology;
and Gastrointestinal, Immunologic, and Special Population Pharmacology. Every question has
been written originally for the Academic Year 2026/2027 to reinforce the official University
of South Alabama College of Nursing NU 578 Units 1-5 course objectives, supporting actual
exam readiness, clinical proficiency, and safe prescriptive decision-making. Each item pairs a
clinically accurate stem with four options and a concise rationale grounded in foundational
advanced pharmacology textbooks and current prescribing guidelines, so the reasoning behind
every correct option is transparent and instructive. Work through each domain in sequence,
record your results on the domain score tracker, and revisit the rationales for any question you
miss before sitting your actual exam.
Domain 1: Pharmacokinetics, Pharmacodynamics, and Drug Interactions (Qs 1-50)
Domain 2: Cardiovascular, Respiratory, and Renal Pharmacology (Qs 51-100)
Domain 3: Neurologic, Psychiatric, and Endocrine Pharmacology (Qs 101-150)
Domain 4: Gastrointestinal, Immunologic, and Special Population Pharmacology (Qs 151-200)
DOMAIN 1: Pharmacokinetics, Pharmacodynamics, and Drug Interactions
Questions 1-50
Question 1. A patient with acute angina is instructed to use sublingual nitroglycerin rather
than an oral tablet. Which pharmacokinetic principle explains this route selection?
A. The sublingual route produces a longer duration of action than the oral route
B. Nitroglycerin is too acidic to be absorbed from the stomach
C. Extensive hepatic first-pass metabolism inactivates oral nitroglycerin, while sublingual
absorption bypasses the portal circulation
,D. Oral nitroglycerin induces its own metabolism within the first week
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass hepatic metabolism, so little intact
drug survives the portal circulation after oral dosing. Sublingual absorption enters systemic
capillaries directly, producing therapeutic levels within one to three minutes, which is why
this route is chosen for rapid relief.
Question 2. A loading dose of phenytoin is ordered before maintenance therapy begins.
What is the purpose of a loading dose?
A. It prevents saturation of hepatic metabolic enzymes
B. It rapidly fills the volume of distribution so therapeutic plasma concentration is reached
without waiting for gradual accumulation
C. It shortens the elimination half-life of the drug
D. It reduces plasma protein binding to free more drug
Correct Answer: B
Rationale: A loading dose equals the desired plasma concentration multiplied by the
volume of distribution. Because phenytoin has a long half-life, reaching steady state by
simple accumulation could take a week or longer; a loading dose achieves therapeutic
concentrations promptly.
Question 3. A patient starts metoprolol tartrate 25 mg twice daily. Approximately how
long does it take to reach steady-state plasma concentrations with consistent dosing?
A. About four to five elimination half-lives
B. After the first dose reaches its peak concentration
C. After ten elimination half-lives
D. Once renal excretion exceeds hepatic metabolism
Correct Answer: A
Rationale: With fixed intermittent dosing, plasma concentrations accumulate toward
steady state in a first-order fashion, reaching about ninety-four percent after four half-
lives and ninety-seven percent after five. Accumulation therefore depends on the half-life,
not on the timing of the first peak.
,Question 4. When a patient's daily phenytoin dose is increased from 300 mg to 400 mg,
the plasma level rises disproportionately. What explains this observation?
A. Plasma protein binding rises at higher concentrations
B. Competition develops for renal tubular secretion
C. Hepatic metabolism becomes saturated, producing zero-order kinetics within the
therapeutic range
D. Gastric emptying is delayed at higher doses
Correct Answer: C
Rationale: Phenytoin is a classic example of a drug that saturates its metabolizing
enzymes at clinical concentrations. Once enzyme capacity is exceeded, a constant amount
is metabolized per unit time, so small dose increases produce large, unpredictable jumps
in plasma level; titration proceeds in small increments with level monitoring.
Question 5. Rifampin is added for a patient stabilized on warfarin. What should the
prescriber anticipate?
A. An elevated INR from inhibited warfarin metabolism
B. No interaction, because rifampin does not affect hepatic enzymes
C. Increased warfarin protein binding with reduced effect
D. A reduced INR from hepatic enzyme induction, often requiring a warfarin dose increase
with close monitoring
Correct Answer: D
Rationale: Rifampin is a potent inducer of CYP2C9 and CYP3A4, which accelerates
warfarin clearance and weakens anticoagulation over one to two weeks. The INR is
monitored closely and the warfarin dose adjusted; when rifampin is discontinued, the
induction fades and the dose must be reduced again.
Question 6. Clarithromycin is prescribed for a patient taking simvastatin 40 mg daily.
What is the safest prescriber action?
A. Temporarily hold the statin or switch to a statin not dependent on CYP3A4
B. Double the simvastatin dose during the infection
C. Add coenzyme Q10 to neutralize the interaction
D. Continue both agents unchanged because no interaction exists
Correct Answer: A
, Rationale: Clarithromycin strongly inhibits CYP3A4, markedly raising simvastatin exposure
and the risk of myopathy and rhabdomyolysis. Holding the statin or using pravastatin or
rosuvastatin, which avoid CYP3A4 metabolism, removes the hazard during the
antimicrobial course.
Question 7. Trimethoprim-sulfamethoxazole is started for a patient taking warfarin. Which
interaction is most important to monitor in the first several days?
A. Permanent induction of warfarin metabolism
B. Inactivation of warfarin within the intestinal lumen
C. Displacement of warfarin from albumin transiently raises the free fraction and the
anticoagulant effect
D. Doubling of warfarin protein binding with reduced effect
Correct Answer: C
Rationale: Both drugs are highly protein bound; sulfonamide competition displaces
warfarin from albumin, transiently increasing free drug until elimination re-equilibrates.
Combined with CYP2C9 inhibition by the combination agent, the INR can climb, so early
INR monitoring and bleeding precautions are warranted.
Question 8. A 78-year-old patient with a creatinine clearance of 24 mL/min requires
enoxaparin for deep vein thrombosis. What prescribing adjustment is required?
A. Give the standard dose because enoxaparin is cleared hepatically
B. Reduce the treatment dose and lengthen the dosing interval because renal elimination
causes accumulation
C. Double the prophylactic dose to compensate for renal function
D. Administer the drug by deep intramuscular injection instead
Correct Answer: B
Rationale: Low-molecular-weight heparins are cleared renally, so severe renal impairment
leads to accumulation and bleeding. Treatment dosing is reduced to once daily (1 mg/kg)
when creatinine clearance falls below 30 mL/min, or unfractionated heparin is selected
because its shorter effect can be managed rapidly if bleeding occurs.
Question 9. Amiodarone is initiated for a patient taking digoxin 0.25 mg daily. What
change should be made?
A. Increase digoxin because amiodarone induces its metabolism
B. No dose change is needed for this combination
